Clarivate Buys Patent Info Business SequenceBase

Innovation insights and data provider Clarivate Analytics has acquired US firm SequenceBase, which provides patent sequence information and search technology to the biotech, pharmaceutical and chemical industries. Terms of the deal have not been disclosed.

The acquisition complements the GENESEQ database run by Clarivate company Derwent's, along with patent research platform Derwent Innovation, providing users with a solution to search, analyze and find context in sequence data within patents. According to Clarivate, a typical new drug can cost over $2bn to bring to market, and the acquisition of SequenceBase will allow Derwent users to find the answers they seek faster when pursuing new biologics innovation.

Martin Goffman, CEO and President of SequenceBase says the combination of his firm's search interface and sequence data with Derwent's curated and enriched databases will improve the workflow of biologic researchers and IP professionals around the world. Dan Videtto, President of Derwent, adds: 'Through the combination of the SequenceBase platform with proprietary USGENE and WOGENE databases and GENESEQ content, customers can now better understand the sequence landscape, enabling them to quickly assess patentability, identify potential infringing patents and track competitor activities'.

Web sites: www.clarivate.com and www.sequencebase.com .